Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
259.36
+5.57 (2.19%)
At close: Oct 20, 2026, 4:00 PM EDT
258.32
-1.04 (-0.40%)
Pre-market: Oct 21, 2026, 5:32 AM EDT

Johnson & Johnson Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
26,80414,06635,15317,94120,878
Depreciation & Amortization
7,5037,3397,1036,3296,651
Loss (Gain) From Sale of Assets
-263-226-117-380-617
Asset Writedown & Restructuring Costs
3132,2461,7781,216989
Stock-Based Compensation
1,3541,1761,1621,1381,135
Provision & Write-off of Bad Debts
-111--17-48
Other Operating Activities
1,538-2,183-4,194-1,663-2,079
Change in Accounts Receivable
-1,781-406-624-1,290-2,402
Change in Inventory
-1,450-1,128-1,323-2,527-1,248
Change in Accounts Payable
2,3771,6212,3461,0982,437
Change in Other Net Operating Assets
-11,8641,7502,108-1,292-3,025
Operating Cash Flow
24,53024,26622,79121,19423,410
Operating Cash Flow Growth
1.09%6.47%7.54%-9.47%-0.53%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-4,832-4,424-4,381-3,706-3,652
Sale of Property, Plant & Equipment
720675358543711
Cash Acquisitions
-17,541-15,146--17,652-60
Sale (Purchase) of Intangibles
-385-1,783-470--
Investment in Securities
7417368,4849,225-5,388
Other Investing Activities
-2,2911,343-3,113-781-294
Investing Cash Flow
-23,588-18,599878-12,371-8,683

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
14,58615,27713,74316,1341,997
Long-Term Debt Issued
9,1386,660-25
Total Debt Issued
23,72421,93713,74316,1362,002
Short-Term Debt Repaid
-12,330-9,463-22,973-6,550-1,190
Long-Term Debt Repaid
-1,757-1,453-1,551-2,134-1,802
Total Debt Repaid
-14,087-10,916-24,524-8,684-2,992
Net Debt Issued (Repaid)
9,63711,021-10,7817,452-990
Issuance of Common Stock
3,4188381,0941,3291,036
Repurchase of Common Stock
-5,953-2,432-5,054-6,035-3,456
Common Dividends Paid
-12,381-11,823-11,770-11,682-11,032
Other Financing Activities
-260-73610,68665395
Financing Cash Flow
-5,539-3,132-15,825-8,871-14,047

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
201-289-112-312-178
Net Cash Flow
-4,3962,2467,732-360502

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
19,69819,84218,41017,48819,758
Free Cash Flow Growth
-0.73%7.78%5.27%-11.49%-2.14%
Free Cash Flow Margin
20.91%22.34%21.62%21.86%25.09%
Free Cash Flow Per Share
8.118.177.196.577.39
Levered Free Cash Flow
16,63316,66619,95215,39615,771
Unlevered Free Cash Flow
17,24017,13820,43415,56815,885

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Interest Paid
1,8631,9111,766933941
Cash Income Tax Paid
6,5396,7148,5745,2234,768
Change in Working Capital
-12,7181,8372,507-4,011-4,238
SEC Filings: 10-K · 10-Q